Stocks and Investing
Stocks and Investing
Tue, November 10, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 9, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (YMAB) at Strong Buy with Increased Target to $65 on, Nov 9th, 2020
Robert Burns of HC Wainwright & Co., Maintained "Y-mAbs Therapeutics, Inc." (YMAB) at Strong Buy with Increased Target from $52 to $65 on, Nov 9th, 2020.
Robert has made no other calls on YMAB in the last 4 months.
There is 1 other peer that has a rating on YMAB. Out of the 1 peers that are also analyzing YMAB, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Geoff Meacham of "B of A Securities" Upgraded from Hold to Strong Buy and Decreased Target to $46 on, Wednesday, October 7th, 2020
Contributing Sources